Nano Dimension Ltd.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Accrued liabilities consist of the following:
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Employees and related liabilities | $7,654 | $7,589 |
| Professional services | 2,533 | 2,209 |
| Government authorities | 2,210 | 2,870 |
| Contingencies | 3,268 | 2,123 |
| Current portion of settlement payable | 2,000 | 2,000 |
| Other | 3,418 | 2,723 |
| Accrued liabilities | $21,083 | $19,514 |
Note 9 – Equity
Share capital activity was as follows (in thousands of shares of NIS 5 par value per share):
| Ordinary shares | ||
|---|---|---|
| 2026 | 2025 | |
| Shares outstanding as of January 1 | 206,812 | 215,777 |
| Exercise of share options and vesting of RSUs during the period | 1,174 | 1,315 |
| Shares outstanding as of March 31 | 207,986 | 217,092 |
Rights Plan
In January 2024, the Company entered into a rights agreement, or the Original Rights Plan. The Original Rights Plan was designed to reduce the likelihood that any entity, person or group would gain control of, or significant influence over the Company. The Original Rights Plan expired on January 25, 2025.
In February 2026, the Company entered into a rights agreement, or the Rights Plan. The Rights Plan was designed to reduce the likelihood that any entity, person or group would gain control of, or significant influence over the Company. The Rights Plan will expire on February 1, 2027.
Stock Options, RSUs and Warrants
The Company has in effect the Employee Stock Option Plan (2015) (the “2015 Plan”).
The 2015 Plan was adopted by Company’s board of directors in February 2015, and expired in February 2026. On December 4, 2025, the shareholders of the Company approved a resolution to extend the 2015 Plan by an additional one-year period ending in February 2027. The Company’s employees, directors, officers, consultants, advisors, and suppliers are eligible to participate in this plan.
On March 13, 2019, the Company’s board of directors adopted an appendix to the 2015 Plan for U.S. residents. Under this appendix, the 2015 Plan provides for the granting of options to U.S. residents in compliance with the U.S. Internal Revenue Code of 1986, as amended.
Of these outstanding awards, as of March 31, 2026,290,834 options to purchase ordinary shares were vested and exercisable.
Stock options
The share options vest over a period of four years. The share options will be exercisable, in consideration of an exercise price, until the earlier of (a) the anniversary of the vesting date of such options, or (b) 90 days from the end of employment date.
A summary of the Company’s stock option activity and related information is as follows:
| Numberof options | Weightedaverageexercise price | Weightedaverageintrinsic value | |
|---|---|---|---|
| Outstanding on December 31, 2025 | 298,334 | $3.57 | $0.02 |
| Granted | — | — | — |
| Exercised | — | — | — |
| Forfeited and expired | — | — | — |
| Outstanding on March 31, 2026 | 298,334 | 3.57 | 0.03 |
| Exercisable as of March 31, 2026 | 290,834 | 3.59 | 0.03 |
The total intrinsic value of options exercised during the three months ended March 31, 2026 and 2025 were none and $0.1 million, respectively.
The weighted average remaining contractual life of the outstanding options is 2.4 years as of March 31, 2026.
Restricted stock units (“RSU”)
A summary of the Company’s RSU activity is as follows:
| Weighted | ||
|---|---|---|
| average | ||
| Number of Units | grant price | |
| Outstanding on December 31, 2025 | 6,222,034 | $1.86 |
| Granted | 1,081,040 | 1.56 |
| Vested | (1,174,412) | 2.21 |
| Forfeited | (96,971) | 1.82 |
| Outstanding on March 31, 2026 | 6,031,691 | $1.75 |
The weighted average fair values at grant date of RSUs granted for the three months ended March 31, 2026 and 2025 were $1.56 and $2.26 per share, respectively.
The total fair value of shares vested during the three months ended March 31, 2026 and 2025 was $3.0 million and $1.3 million, respectively. As of March 31, 2026, there were 927,833 RSUs that were vested but not issued and outstanding due to timing. As such, these shares are excluded from the vested amount in the above table and are included as outstanding RSUs.
As of March 31, 2026, the Company had approximately $7.2 million of unrecognized compensation expense related to non-vested stock options and non-vested RSU’s, expected to be recognized over a weighted average period of 1.6 years.
Warrants
A summary of the Company’s warrants activity and related information is as follows:
| Weighted | |||
|---|---|---|---|
| average | |||
| Weighted · remaining | |||
| average · contractual | |||
| exercise · life (in | |||
| Warrants | price | years) | |
| Outstanding on December 31, 2025 | 29,242,103 | $5.96 | 1.60 |
| Granted | — | — | — |
| Exercised | — | — | — |
| Expired | — | — | — |
| Outstanding and exercisable as of March 31, 2026 | 29,242,103 | $5.96 | 1.60 |
As of March 31, 2026, the outstanding warrants include 27,742,103 Series B warrants issued to Stern YOI Ltd. Partnership in August 2020 to purchase Ordinary Shares at an exercise price of $6.16 per ADS and expiring in August 2027. Stern YOI Ltd. Partnership is a Nevada limited partnership. Mr. Yoav Stern, former Chief Executive Officer of Nano Dimension Ltd., is a managing member of Stern YOI Ltd. Partnership. In September 2020, the Company issued 1,500,000 warrants to purchase 1,500,000 ADSs to the Company’s former director, Mr. Yaron Eitan, in consideration of $150,000. The warrants have an exercise price of $2.25 per ADS and will expire in September 2027.
Stock-Based Compensation
Stock-based compensation expense related to stock options and RSUs is included in the condensed consolidated statements of operations and comprehensive loss as follows:
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cost of revenue | $158 | $246 |
| Research and development expenses | 478 | 69 |
| Sales and marketing expenses | 200 | 323 |
| General and administrative expenses | 2,089 | (1,424) |
| $2,925 | $(786) | |
Note 10 – Revenue
The Company has one operating and reportable segment, which generates revenue via industrial manufacturing solutions of multi-disciplinary technology - combining hardware, software, and materials science.
Revenue per geographical location is as follows:
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Americas | $12,256 | $4,756 |
| APAC | 4,695 | 1,490 |
| EMEA | 12,774 | 8,155 |
| Total revenue | $29,725 | $14,401 |
The following table disaggregates the Company's revenue by the timing of transfer of products or services:
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Services transferred over time | $5,093 | $1,387 |
| Goods transferred at a point in time | 24,632 | 13,014 |
| Total revenue | $29,725 | $14,401 |
Contract balances
Timing of revenue recognition may differ from the timing of invoicing to customers. The Company has a right to bill when products are shipped, which is often the point in time revenue is recognized. As a result, the Company will have accounts receivable for billings and also deferred revenue for the portion of billings in advance of service in its hardware maintenance agreements.
The Company recognized $4.2 million of revenue during thethree months ended March 31, 2026 from deferred revenue as of December 31, 2025. The Company recognized $1.0 million of revenue during thethree months ended March 31, 2025 from deferred revenue as of December 31, 2024.
Deferred revenue is expected to be recognized when the Company provides hardware maintenance services or contractual performance obligations for which the customer has already provided payment with $12.3 million to be recognized in the remainder of 2026, $2.8 million in 2027, $1.0 million in 2028, and $0.4 million thereafter. These deferred revenues are included within other long-term liabilities on the condensed consolidated balance sheets.
Note 11 – Commitments and contingencies
From time to time, the Company may face legal claims or actions in the normal course of business. At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that address accounting for contingencies. The Company expenses the costs related to its legal proceedings as incurred.
On September 20, 2024, Markforged entered into a settlement agreement with Continuous Composites related to previous litigation (the “Settlement Agreement”) to resolve all claims and counterclaims. Under the terms of the Settlement Agreement, Markforged made an initial upfront payment of $18 million to Continuous Composites on October 10, 2024, and is required to make three additional installment payments thereafter of $1 million, $2 million and $4 million in the fourth quarters of fiscal years 2025, 2026 and 2027, respectively. In consideration of such payments, the Settlement Agreement provides for a dismissal of all claims with prejudice, cross-licenses of the parties’ respective patent portfolios, a mutual release of claims for liabilities arising prior to the effective date of the Settlement Agreement and mutual covenants not to sue. The incremental amount due under the Settlement Agreement compared to the original verdict is determined to be representative of the amount attributable to the licensing of the patent rights contemplated under the Settlement Agreement and was recognized as an intangible asset of $5.5 million, after discount using a rate of 12%, to be amortized to cost of revenue over the 23 year life of the patents. Total amortization expense of $0.2 million was recognized from the period of acquisition through the year ended December 31, 2025, and included in cost of revenue. The Company paid $1.0 million during 2025 and the remaining future payments of $6.0 million under the Settlement Agreement as of December 31, 2025 are secured by the Security Agreement. The Company has recorded a settlement payable on the condensed consolidated balance sheet of $5.0 million, of which $2.0 million is a current liability. The settlement payable will accrete $1.0 million over the remaining payment term recognized as interest expense. Interest expense related to settlement payable was $0.1 million for the three months ended March 31, 2026.
On July 8, 2025, Quinn Emanuel Urquhart & Sullivan, LLP (“Quinn”) filed a lawsuit against Nano Dimension Ltd. and Ofir Baharav (“Defendants”). Quinn alleges that Defendants tortiously interfered with Quinn’s contract with Desktop Metal, and prevented Desktop Metal from paying Quinn approximately $30.0 million. Quinn also asserts that Defendants are liable pursuant to an alleged attorney’s lien and engaged in unfair and deceptive practices, in violation of Massachusetts law. The case is pending in the Business Litigation Session of the Suffolk Superior Court in Massachusetts. Defendants moved to dismiss. That motion was fully briefed in February 2026, argued on March 16, 2026, and remains pending.
During the third quarter of 2025, certain former employees or vendors of the Company or its subsidiaries filed lawsuits alleging that the Company is in breach of certain agreements and are entitled to certain compensation and other benefits. While other matters are still ongoing, the Company believes that it is probable that some amount of loss has been incurred and has accrued approximately $2.2 million, including an increase of $1.1 million during the first quarter of 2026 as an estimated probable loss which is included as part of general and administrative operating expenses.
During the fourth quarter of 2025, Markforged processed a $1.4 million payment to an account believed to be controlled by one of our vendors, however it was subsequently discovered that this account was not owned by the vendor. The Company suspects that a threat actor gained access to a valid email account of the vendor and used this account to fraudulently change payment instructions. The Company has notified its insurance carrier and engaged breach counsel as well as a forensics partner to help with the investigation. Pending conclusion of the investigation, approximately $1.0 million has been accrued at December 31, 2025 and March 31, 2026 as the estimated amount of probable loss which is included as part of general and administrative operating expenses.
Note 12 – Income Tax
The Company’s effective tax rate was 0.0% for the three months ended March 31, 2026 and 2025. The reconciliation between the Israel statutory federal income tax rate of 23% and the effective tax rate primarily reflects pre-tax losses incurred in domestic and foreign jurisdictions for which no tax benefit was recognized due to a valuation allowance recorded against the majority of deferred tax assets. The Company maintained a valuation allowance against its deferred tax assets as of both March 31, 2026 and December 31, 2025.
Note 13 – Segments
Operating segments are defined as components of an entity for which separate financial information is available and regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company’s CODM is its Chief Executive Officer.
The CODM evaluates the Company’s financial information and resources and assesses the performance of these resources on a consolidated basis using adjusted EBITDA.
Adjusted EBITDA is a non-GAAP measure defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization, share-based compensation expense, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and Markforged transaction related expenses, restructuring costs, impact of deconsolidation, impairment losses, litigation settlements and contingencies and step-up amortization from purchase accounting. We believe that Adjusted EBITDA and operating expenses, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payments, restructuring costs, impairment losses, and step-up amortization from purchase accounting. Adjusted EBITDA and operating expenses are useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to non-cash items, such as expenses related to share-based payments.
There is not any revenue, expense, or asset information, that is supplemental to those disclosed in these condensed consolidated financial statements or below, that are regularly provided to the CODM for evaluation of thesingle operating segment. The adjusted EBITDA reconciliations for thethree months ended March 31, 2026 and 2025 are as follow:
| For the Three Months Ended March 31, 2026 | |
|---|---|
| Operating Segment | |
| Net loss | $(53,456) |
| Depreciation and amortization | 2,361 |
| Interest income and expense, net | 211 |
| EBITDA (loss) | (50,884) |
| Exchange rate differences | (206) |
| Share-based compensation expense | 917 |
| Impairment losses | 40,388 |
| Acquisition inventory step-up amortization | 616 |
| Segment adjusted EBITDA (loss) | $(9,169) |
| Reconciliation of segment adjusted EBITDA (loss): | |
| Operating segment adjusted EBITDA (loss) | $(9,169) |
| Corporate reconciling items: | |
| Net loss(1) | (16,206) |
| Depreciation and amortization | 71 |
| Interest income and expense, net | (3,642) |
| Finance expenses (income) from revaluation of assets and liabilities | 8,434 |
| Exchange rate differences | 346 |
| Share-based compensation expense | 2,008 |
| Desktop Metal and Markforged transaction related expenses | 556 |
| Restructuring costs | 3,127 |
| Litigation, settlements, and contingencies | 1,951 |
| Adjusted EBITDA (loss) | $(12,524) |
(1) Net loss in corporate adjustments relate to those costs incurred at the parent company level, such as financing gains and losses, gains and losses on marketable securities, and corporate overhead costs inclusive of public company costs, legal, corporate headcount, and real estate related costs.
| For the Three Months Ended March 31, 2025 | |
|---|---|
| Operating Segment | |
| Net loss | $(11,000) |
| Income tax (benefit) expense | 23 |
| Depreciation and amortization | 513 |
| EBITDA (loss) | (10,464) |
| Exchange rate differences | 239 |
| Share-based compensation expense | 705 |
| Impairment losses | 1,229 |
| Segment adjusted EBITDA (loss) | $(8,291) |
| Reconciliation of segment adjusted EBITDA (loss): | |
| Operating segment adjusted EBITDA (loss) | $(8,291) |
| Corporate reconciling items: | |
| Net loss(1) | (14,548) |
| Depreciation and amortization | 61 |
| Interest income and expense, net | (9,309) |
| Finance expenses (income) from revaluation of assets and liabilities | (8,726) |
| Exchange rate differences | 1,400 |
| Share-based compensation expense | (1,491) |
| Desktop Metal litigation related expenses | 28,069 |
| Desktop Metal and Markforged transaction related expenses | 1,515 |
| Restructuring costs | 1,180 |
| Adjusted EBITDA (loss) | $(10,140) |
Note 14 – Net Profit (Loss) Per Share
The Company computes basic net profit (loss) per share using net profit (loss) attributable to the Company’s common shareholders and the weighted-average number of common shares outstanding during each period. Diluted earnings per share include shares issuable upon exercise of outstanding stock options and stock-based awards where the conversion of such instruments would be dilutive. The Company does this through the treasury stock method. The calculations presented below represent the basic and diluted net profit (loss) per share for all classes of securities.
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Numerator: | ||
| Net loss | $(69,662) | $(25,548) |
| Less: Net loss attributable to non-controlling interests | — | (236) |
| Net loss attributable to common shareholders | $(69,662) | $(25,312) |
| Denominator: | ||
| Weighted-average shares outstanding - Basic | 207,504 | 216,462 |
| Add: Weighted average unvested options and warrants outstanding | — | — |
| Add: Dilutive effect of restricted units issued | — | — |
| Weighted-average shares outstanding - Diluted | 207,504 | 216,462 |
| Net loss per common share: | ||
| Basic and Diluted | ||
| Net loss attributable to common shareholders | $(0.34) | $(0.12) |
For the three months ended March 31, 2026 and 2025, the Company was in a net loss position, thus the effect of potentially dilutive securities was excluded from the denominator for the calculation of diluted net loss per share because the inclusion of such securities would be antidilutive. The following dilutive securities are excluded from the denominator:
| For the three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Unvested or unexercised option awards | 298,334 | 2,465,035 |
| Unvested RSUs | 6,031,691 | 8,883,576 |
| Warrants | 29,242,103 | 33,680,126 |
| Total | 35,572,128 | 45,028,737 |
Note 15 – Subsequent Events
On April 6, 2026, the Company announced the sale of its additively manufactured electronics (AME) product line and their previously discontinued Fabrica product line to Inspira Technologies OXY B.H.N. Ltd. (“Inspira”). The total consideration payable in connection with the transaction is up to $12.5 million, consisting of a $2.0 million upfront cash payment, and up to $10.5 million of deferred payments tied to the future performance of the product lines over the next twelve months. Inspira assumed operational control of the product lines effective immediately. Completion of the transaction remains subject to the receipt of customary regulatory approvals. The Company has determined that the carrying value of the assets sold approximates the estimated fair value of the consideration. Accordingly, the Company does not expect to recognize a material gain or loss.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.